Clinical Trial Update: Interim PET/CT Guided Cycle Numbers of R-CHOP in DLBCL [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates using interim PET/CT responses to guide the number of R-CHOP chemotherapy cycles in Diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Fudan University | Conditions: Diffuse Large B-cell Lymphoma | Phase 2 | Status: UNKNOWN